BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 2, 2006
View Archived Issues
BYK-191023: new selective iNOS inhibitor and candidate for inflammatory hypotension
Read More
Meta-analysis indicates beneficial effects of Chinese herbal medicine for NSCLC
Read More
Recent patents describe novel analgesic agents
Read More
A new role for Cdk5 in pain signaling
Read More
Enrollment ahead of schedule in Onconase phase IIIb study
Read More
AVI signs HCV license agreement with Chiron
Read More
Daiichi reports new agents for treating allergic disorders
Read More
Novel ophthalmic compounds described by Alcon in a recent patent
Read More
Recent patents disclose novel agents for cardiovascular disorders
Read More
PKC-412 and AMN-107 show promise in systemic mastocytosis with mutated KIT
Read More
MediGene and Bradley sign agreement for Polyphenon E Ointment
Read More
Pharmion and MethylGene sign agreement for oncology oral HDAC inhibitors
Read More
Synergistic activity seen with FK-228 and bortezomib in leukemic cells
Read More
AOD-9604 shows potential for osteoporosis
Read More
Ferring and Astellas sign licensing agreement for degarelix in Japan
Read More
BTG acquires rights to Asterand's pain compounds
Read More
Orphan drug designation for TheraQuest's high-concentration capsaicin
Read More
Benitec delays IND filing for HIV/AIDS therapeutic
Read More
SNS-032 begins phase I study in advanced solid tumor cancers
Read More
Phase II trial planned for Cloretazine in elderly poor-risk AML patients
Read More
Locus and Lilly enter research agreement
Read More
FDA accepts IND for OxyQD
Read More
Enrollment completed in phase II stress urinary incontinence study of cizolirtine
Read More
U.S. launch for Avandaryl
Read More
Amitiza approved for chronic idiopathic constipation
Read More
GlaxoSmithKline's Arranon launched for the first time in the U.S.
Read More